Q2 2022 Celyad Oncology SA Earnings Call Transcript
Greetings and welcome to the Celyad Oncology first half 2022 financial results. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Sara Zelkovic, Director of Communications & Investor Relations for Celyad Oncology. Thank you. You may begin.
Thank you all for joining us today. Before we begin, I would like to remind everyone that today's event may contain forward-looking statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may involve known and unknown risks and uncertainties, which might cause actual results, financial condition, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
A list and description of these risks, uncertainties, and other risks can be found in the company's U.S. Securities and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
